Purpose
to pilot the use of rapid assays for surveillance of known SARS-CoV-2 variants of concern in Africa
Grantee
Division
Global Health
Date
OCTOBER 2021
Region served
AFRICA
Committed amount
$562,000
Grant topic
Vaccine Development
Duration (months)
22
Grantee location
Addis Ababa, Addis Ababa, Ethiopia
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.